Shares of N4 Pharma Plc (LON:N4P – Get Free Report) dropped 25% during mid-day trading on Monday . The stock traded as low as GBX 0.41 ($0.01) and last traded at GBX 0.45 ($0.01). Approximately 3,201,853 shares changed hands during trading, an increase of 201% from the average daily volume of 1,064,697 shares. The stock had previously closed at GBX 0.60 ($0.01).
N4 Pharma Stock Performance
The firm has a fifty day moving average of GBX 0.70 and a 200-day moving average of GBX 0.78. The stock has a market capitalization of £1.21 million, a price-to-earnings ratio of -52.50 and a beta of -0.07. The company has a quick ratio of 7.28, a current ratio of 14.86 and a debt-to-equity ratio of 1.62.
About N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than N4 Pharma
- What Are Dividend Challengers?
- Micron Technology Stock Volatile Despite Analyst Upgrades
- How to Start Investing in Real Estate
- McDonald’s Stock: Balancing Value and Innovation
- About the Markup Calculator
- MarketBeat Week in Review – 6/17 – 6/21
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
